I. Sklenar
Impact in
- Hematology top 10%
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Parasitology top 10%
- Toxoplasma gondii Research Studies
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 6
- Colorectal Cancer Treatments and Studies 2
-
- Polyamine Metabolism and Applications 3
- Co-authors
- Peter Erb (4 shared papers)Ş. Ş. Alkan (1 shared paper)Terry C. Jones (1 shared paper)Terence J. Wilkin (1 shared paper)Marco Bregni (2 shared papers)Ulrich Keller (1 shared paper)A. Johri (5 shared papers)Salvatore Siena (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Cancer Research (3 papers)Diabetes Care (1 paper)Bone Marrow Transplantation (1 paper)Annals of Oncology (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
I. Sklenar
21 papers receiving 362 citations
Peers
Comparison fields: 5 of 54
- Hematology 80
- Parasitology 38
- Biochemistry 40
- Oncology 67
- Pharmacology 42
Countries citing papers authored by I. Sklenar
This map shows the geographic impact of I. Sklenar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Sklenar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Sklenar more than expected).
Fields of papers citing papers by I. Sklenar
This network shows the impact of papers produced by I. Sklenar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Sklenar. The network helps show where I. Sklenar may publish in the future.
Co-authors
The 25 scholars most cited alongside I. Sklenar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 45 | |
| 2 | 1986 | 40 | |
| 3 | Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. | 1993 | 38 |
| 4 | 2003 | 37 | |
| 5 | 1987 | 35 | |
| 6 | A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies. | 2002 | 33 |
| 7 | 2007 | 30 | |
| 8 | 1993 | 17 | |
| 9 | 2004 | 16 | |
| 10 | 2005 | 14 | |
| 11 | 1977 | 13 | |
| 12 | 1985 | 12 | |
| 13 | 2006 | 12 | |
| 14 | 1982 | 7 | |
| 15 | 1997 | 6 | |
| 16 | 2005 | 6 | |
| 17 | 1998 | 5 | |
| 18 | 2005 | 3 | |
| 19 | 1999 | 2 | |
| 20 | 1985 | 2 |
About I. Sklenar
I. Sklenar is a scholar working on Oncology, Molecular Biology, Hematology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 23 papers that have together received 376 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Hematopoietic Stem Cell Transplantation (3 papers), Immune Cell Function and Interaction (3 papers), Polyamine Metabolism and Applications (3 papers), Diabetes and associated disorders (2 papers), T-cell and B-cell Immunology (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Hematology (80 citations), Parasitology (38 citations), Biochemistry (40 citations), Oncology (67 citations) and Pharmacology (42 citations). I. Sklenar has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Peter Erb, Ş. Ş. Alkan, Terry C. Jones, Terence J. Wilkin, Marco Bregni, Ulrich Keller, A. Johri, Salvatore Siena, José-Luis Dı́az and Carl W. Porter. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Diabetes Care, Bone Marrow Transplantation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.